C M Rzepczyk - Concepedia

Author

C M Rzepczyk

QIMR Berghofer Medical Research Institute

Also Known As

, C M Rzepczyk, C Rzepczyk, C. M. RZEPCZYK, C. M. Rzepczyk, C. Rzepczyk, C.M Rzepczyk, C.M. Rzepczyk, CHRISTINE M. RZEPCZYK, CHRISTINE RZEPCZYK

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

QIMR Berghofer Medical Research Institute Women's and Children's Hospital The University of Adelaide Australian Red Cross Lifeblood Royal Brisbane and Women's Hospital

About

C M Rzepczyk is an author at QIMR Berghofer Medical Research Institute specializing in medicine, malaria, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.4K
2	Natural Sciences	4	4	142
3	Allergy	3	3	157
4	Biochemistry	3	3	91
5	Anatomy	2	2	49

C M Rzepczyk

Publications

Citations

H-Index

Page 1

	Year	Citations
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum D Pombo, Gregor Lawrence, Chakrit Hirunpetcharat, The Lancet Ultra-low DosesMalariaImmunologyRed CellsVector-parasite Relationship	2002	403
Identification of two promiscuous T cell epitopes from tetanus toxin Paul C. Ho, David A. Mutch, Kenneth D. Winkel, European Journal of Immunology	1990	143
Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers Gregor Lawrence, Qin Cheng, Carol Reed, Vaccine VaccinationNon-immune VolunteersMalariaImmunologyParasite Control	2000	140
Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant Allan Saul, Gregor Lawrence, Anne Smillie, Vaccine VaccinationVaccine DevelopmentMalariaImmunologyHuman Phase	1999	139
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant Allan Saul, Gregory J. Lawrence, Anthony Allworth, Vaccine VaccinationMalariaImmunologyHuman Phase 1Vaccine Clinical Trial	2005	109
The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects L.M. Kumaratilake, Antonio Ferrante, C M Rzepczyk The Journal of Immunology	1991	77
Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass C M Rzepczyk, Karen Hale, N Woodroffe, Infection and Immunity Plasmodium Falciparum ShowAutoimmune DiseaseMalariaImmunologyPathogenesis	1997	72
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum L.M. Kumaratilake, Antonio Ferrante, C M Rzepczyk Infection and Immunity InflammationTumor Necrosis FactorPlasmodium FalciparumAutoimmune DiseaseAntiparasitic Agent	1990	72
Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites L.M. Kumaratilake, Antonio Ferrante, T Jaeger, Infection and Immunity Phagocytic ResponsePlasmodium Falciparum MerozoitesAntiparasitic AgentMalariaImmunology	1992	60
Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages) Antonio Ferrante, L.M. Kumaratilake, C M Rzepczyk, Immunology Letters InflammationCytokineAntiparasitic AgentGranulocyteMalaria	1990	58

Page 1